BLSX Limited
₹ 26▲0.00%(0.00)
About the company
BLSX Limited is an Indian engineering and industrial manufacturing company incorporated in 2022 and headquartered in Hyderabad, Telangana. The company specializes in designing and manufacturing high-performance industrial components that serve critical applications across infrastructure, mining, defence, aerospace, and heavy engineering industries. With a strong emphasis on quality, innovation, and precision manufacturing, BLSX has established itself as a reliable supplier for customers requiring durable and high-performance industrial solutions.
The company's product portfolio includes a wide range of industrial hoses designed for dredging, slurry handling, discharge operations, and steel plant applications. In addition, BLSX manufactures rubber-to-metal bonded components that are widely used in bridges, defence equipment, aerospace systems, heavy earth-moving machinery, mining equipment, and other demanding industrial environments. These products are engineered to deliver consistent performance, reliability, and long service life, even under challenging operating conditions.
Fundamentals
Valuation
- 52 week high
- ₹32
- 52 week low
- ₹24
- P/B ratio
- 16.99
- Debt to equity
- 0
- ROE (%)
- 12.73%
- Book value
- ₹1.53
- Face value
- ₹1
- Valuation
- —
Registry
- ISIN number
- INE0MDG01016
Figures in cr ·
Financials
| P&L Statement | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 2.76 | 8.97 | 15.09 |
| EBITDA | 0.26 | 2.06 | 2.85 |
| OPM | 9.42 | 22.97 | 18.89 |
| PBT | -0.51 | 1.15 | 2.13 |
| PAT | -0.46 | 0.81 | 1.55 |
| EPS | -0.05 | 0.09 | 0.18 |
Shareholding Pattern
Leadership
| Name | Role | Experience | |
|---|---|---|---|
| Unmesh Trivedi | MD | 20+ yrs experience | — |
| Vipul Trivedi | Chairman | 20+ yrs experience | — |
Frequently asked questions
Common questions on BLSX Limited—tap a row to read the answer.
Q.1What are BLSX Limited unlisted shares?
BLSX Limited unlisted shares are equity shares of the company that are not listed on any recognized stock exchange. These shares are traded through private transactions in the unlisted market, allowing investors to participate in the company's growth before any potential public listing.
Q.2How can I buy BLSX Limited unlisted shares?
You can buy BLSX Limited unlisted shares through registered brokers or intermediaries that facilitate transactions in the unlisted share market. After the buyer and seller agree on the price and quantity, the required documentation is completed, and the shares are transferred to the buyer's Demat account.
Q.3Is it legal to invest in BLSX Limited unlisted shares?
Yes. Investing in BLSX Limited unlisted shares is legal in India as long as the transaction complies with applicable laws and regulatory requirements. Investors should ensure that the shares are transferred through proper channels and credited to their Demat account.
Q.4Why do investors consider BLSX Limited unlisted shares?
Investors may consider BLSX Limited unlisted shares if they believe the company has strong long-term growth potential or could benefit from future business expansion. Investing before a potential public listing may offer attractive opportunities, but it also involves higher risks compared to listed stocks.
Q.5What should I check before investing in BLSX Limited unlisted shares?
Before investing, evaluate the company's financial performance, revenue growth, profitability, management team, business model, industry outlook, debt levels, future expansion plans, and valuation. Reviewing these factors can help you make a more informed investment decision.
Q.6Can I sell BLSX Limited unlisted shares whenever I want?
Yes, provided you can find a willing buyer. Unlike listed shares, BLSX Limited unlisted shares are traded through private transactions rather than on a stock exchange. As a result, the time required to complete a sale depends on buyer availability, agreed pricing, and the completion of transfer formalities.
Trending shares
High-demand unlisted opportunities currently available for trade.
From the blog
Notes on unlisted markets, execution hygiene, and how we think about risk—no hype, no ticker spam.

APTUS PHARMA IPO
Aptus Pharma Limited rolled out its 100% book-built BSE SME public offering worth ₹13.02 Crore. Review crucial parameters for retail investors, featuring the ₹65–₹70 price band, working capital allocations, and an evaluation of its contract-manufacturing partner model.

NEPHROPLUS (NEPHROCARE HEALTH SERVICES) IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

APOLLO TECHNO INDUSTRIES IPO
Apollo Techno Industries Limited has announced its public offering details. Explore the essential investment parameters for retail and institutional bidders, highlighting the fixed price band, lot structure, key market deadlines, and an overview of its industrial manufacturing footprint.

NEOCHEM BIO IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

ANONDITA MEDICARE IPO
Anondita Medicare Limited rolled out its 100% book-built SME public offering worth ₹69.50 Crore on the NSE SME platform. Dig into the critical parameters for investors, highlighting the ₹137–₹145 price band, key working capital objectives, and an analysis of its flagship brand 'COBRA' within the growing sexual wellness market.

NEPTUNE LOGITEK IPO
Explore the Neptune Logitek IPO, including issue details, business strengths, risks, and investment analysis.
